Purdue Pharma LLP is a pharmaceutical company. It lobbies on health-related matters and bankruptcy issues, including preventing abuse and diversion of prescription drugs, prescription drug payment reform, and pharmaceutical supply chain concerns. Filings show it monitored congressional efforts around the SACKLER Act. It reported $250,000 across five filings, most recently on 2026-01-20.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRIAN SUTTER
The latest disclosures for this client.
CAPITOL HILL CONSULTING GROUP
4TCAPITOL HILL CONSULTING GROUP
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CAPITOL HILL CONSULTING GROUP
EMILY ELIZABETH WILKINSON-HOLLAND
CAPITOL HILL CONSULTING GROUP
mr CHRISTOPHER DAVIS
CAPITOL HILL CONSULTING GROUP
CAPITOL HILL CONSULTING GROUP
2ACAPITOL HILL CONSULTING GROUP
Q2CAPITOL HILL CONSULTING GROUP
Q1